BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1757 related articles for article (PubMed ID: 16224390)

  • 1. Potential role of recombinant factor VIIa as a hemostatic agent.
    Hedner U; Erhardtsen E
    Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. General haemostatic agents--fact or fiction?
    Hedner U
    Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():33-6. PubMed ID: 12214145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant factor VIIa: its background, development and clinical use.
    Hedner U
    Curr Opin Hematol; 2007 May; 14(3):225-9. PubMed ID: 17414211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant activated factor VII: its mechanism of action and role in the control of hemorrhage.
    Allen GA; Hoffman M; Roberts HR; Monroe DM
    Can J Anaesth; 2002 Dec; 49(10):S7-14. PubMed ID: 12546000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. To general haemostasis--the evidence-based route.
    Erhardtsen E
    Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():47-52. PubMed ID: 12214148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into the coagulation system and implications for new therapeutic options with recombinant factor VIIa.
    Veldman A; Hoffman M; Ehrenforth S
    Curr Med Chem; 2003 May; 10(10):797-811. PubMed ID: 12678684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of action of factor VIIa in the treatment of coagulopathies.
    Hedner U
    Semin Thromb Hemost; 2006 Apr; 32 Suppl 1():77-85. PubMed ID: 16673269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfusion medicine service policies for recombinant factor VIIa administration.
    Goodnough LT; Lublin DM; Zhang L; Despotis G; Eby C
    Transfusion; 2004 Sep; 44(9):1325-31. PubMed ID: 15318856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant factor VIIa (NovoSeven) as a hemostatic agent.
    Hedner U
    Dis Mon; 2003 Jan; 49(1):39-48. PubMed ID: 12525827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice.
    Murkin JM
    Can J Anaesth; 2002 Dec; 49(10):S21-6. PubMed ID: 12546007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action, development and clinical experience of recombinant FVIIa.
    Hedner U
    J Biotechnol; 2006 Aug; 124(4):747-57. PubMed ID: 16697480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant factor VIIa (Novoseven) as a hemostatic agent.
    Hedner U
    Semin Hematol; 2001 Oct; 38(4 Suppl 12):43-7. PubMed ID: 11735110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of recombinant activated factor VII: an update.
    Hedner U
    Semin Hematol; 2006 Jan; 43(1 Suppl 1):S105-7. PubMed ID: 16427375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prerequisites for recombinant factor VIIa-induced thrombin generation in plasmas deficient in factors VIII, IX or XI.
    Livnat T; Zivelin A; Martinowitz U; Salomon O; Seligsohn U
    J Thromb Haemost; 2006 Jan; 4(1):192-200. PubMed ID: 16409469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue factor-independent effects of recombinant factor VIIa on hemostasis.
    Weeterings C; Lisman T; de Groot PG
    Semin Hematol; 2008 Apr; 45(2 Suppl 1):S12-5. PubMed ID: 18544417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII/FIX.
    He S; Blombäck M; Jacobsson Ekman G; Hedner U
    J Thromb Haemost; 2003 Jun; 1(6):1215-9. PubMed ID: 12871322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosing with recombinant factor viia based on current evidence.
    Hedner U
    Semin Hematol; 2004 Jan; 41(1 Suppl 1):35-9. PubMed ID: 14872419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue factor and factor VIIa as therapeutic targets in disorders of hemostasis.
    Hedner U; Ezban M
    Annu Rev Med; 2008; 59():29-41. PubMed ID: 17845136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel approach to improving recombinant factor VIIa activity with a preserved platelet preparation.
    Campbell RA; Fischer TH; Wolberg AS
    Br J Haematol; 2007 Jul; 138(1):82-93. PubMed ID: 17555451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of platelets on fibrin gel structure formed in the presence of recombinant factor VIIa in hemophilia plasma and in plasma from a patient with Glanzmann thrombasthenia.
    He S; Ekman GJ; Hedner U
    J Thromb Haemost; 2005 Feb; 3(2):272-9. PubMed ID: 15670032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 88.